Machine Learning Sensors for Diagnosis of COVID-19 Disease Using Routine Blood Values for Internet of Things Application

ArticleAçık Erişim

Özet

Healthcare digitalization requires effective applications of human sensors, when various parameters of the human body are instantly monitored in everyday life due to the Internet of Things (IoT). In particular, machine learning (ML) sensors for the prompt diagnosis of COVID-19 are an important option for IoT application in healthcare and ambient assisted living (AAL). Determining a COVID-19 infected status with various diagnostic tests and imaging results is costly and time-consuming. This study provides a fast, reliable and cost-effective alternative tool for the diagnosis of COVID-19 based on the routine blood values (RBVs) measured at admission. The dataset of the study consists of a total of 5296 patients with the same number of negative and positive COVID-19 test results and 51 routine blood values. In this study, 13 popular classifier machine learning models and the LogNNet neural network model were exanimated. The most successful classifier model in terms of time and accuracy in the detection of the disease was the histogram-based gradient boosting (HGB) (accuracy: 100%, time: 6.39 sec). The HGB classifier identified the 11 most important features (LDL, cholesterol, HDL-C, MCHC, triglyceride, amylase, UA, LDH, CK-MB, ALP and MCH) to detect the disease with 100% accuracy. In addition, the importance of single, double and triple combinations of these features in the diagnosis of the disease was discussed. We propose to use these 11 features and their binary combinations as important biomarkers for ML sensors in the diagnosis of the disease, supporting edge computing on Arduino and cloud IoT service. © 2022 by the authors.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12840Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3390/s22207886Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorVelichko, Andrei
dc.contributor.authorHuyut, Mehmet Tahir
dc.contributor.authorBelyaev, Maksim
dc.contributor.authorIzotov, Yuriy
dc.contributor.authorKorzun, Dmitry
dc.date.accessioned2026-10-18T20:27:42.399312456Z
dc.date.available2026-10-18T20:27:42.399312456Z
dc.date.issued2022
dc.description.abstractHealthcare digitalization requires effective applications of human sensors, when various parameters of the human body are instantly monitored in everyday life due to the Internet of Things (IoT). In particular, machine learning (ML) sensors for the prompt diagnosis of COVID-19 are an important option for IoT application in healthcare and ambient assisted living (AAL). Determining a COVID-19 infected status with various diagnostic tests and imaging results is costly and time-consuming. This study provides a fast, reliable and cost-effective alternative tool for the diagnosis of COVID-19 based on the routine blood values (RBVs) measured at admission. The dataset of the study consists of a total of 5296 patients with the same number of negative and positive COVID-19 test results and 51 routine blood values. In this study, 13 popular classifier machine learning models and the LogNNet neural network model were exanimated. The most successful classifier model in terms of time and accuracy in the detection of the disease was the histogram-based gradient boosting (HGB) (accuracy: 100%, time: 6.39 sec). The HGB classifier identified the 11 most important features (LDL, cholesterol, HDL-C, MCHC, triglyceride, amylase, UA, LDH, CK-MB, ALP and MCH) to detect the disease with 100% accuracy. In addition, the importance of single, double and triple combinations of these features in the diagnosis of the disease was discussed. We propose to use these 11 features and their binary combinations as important biomarkers for ML sensors in the diagnosis of the disease, supporting edge computing on Arduino and cloud IoT service. © 2022 by the authors.
dc.description.sponsorshipThe research is implemented with financial support by Russian Science Foundation, project no. 22-11-20040 (https://rscf.ru/en/project/22-11-20040/ (accessed on 14 September 2022)) jointly with Republic of Karelia and funding from Venture Investment Fund of Republic of Karelia (VIF RK).
dc.identifier.doi10.3390/s22207886
dc.identifier.eissn1424-8220
dc.identifier.issn1424-8220
dc.identifier.issue20
dc.identifier.pmcidPMC9610709
dc.identifier.pmid36298235
dc.identifier.scopus2-s2.0-85140834744
dc.identifier.startpage7886
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12840
dc.identifier.volume22
dc.identifier.wosWOS:000873611000001
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofSensors
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectbiochemical and hematological biomarkers
dc.subjectCOVID-19
dc.subjectfeature selection method
dc.subjectInternet of Medical Things
dc.subjectIoT
dc.subjectLogNNet neural network
dc.subjectmachine learning sensors
dc.subjectroutine blood values
dc.subjectAmylases
dc.subjectCholesterol, HDL
dc.subjectHumans
dc.subjectInternet of Things
dc.subjectMachine Learning
dc.subjectTriglycerides
dc.subjectBiomarkers
dc.subjectBlood
dc.subjectCost effectiveness
dc.subjectDiagnosis
dc.subjectFeature Selection
dc.subjectHealth care
dc.subjectLearning algorithms
dc.subjectStatistical tests
dc.subjectamylase
dc.subjecthigh density lipoprotein cholesterol
dc.subjecttriacylglycerol
dc.subjectBiochemical and hematological biomarker
dc.subjectFeature selection methods
dc.subjectGradient boosting
dc.subjectHuman sensors
dc.subjectInternet of medical thing
dc.titleMachine Learning Sensors for Diagnosis of COVID-19 Disease Using Routine Blood Values for Internet of Things Application
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus45
rdl.citation.wos34
rdl.departmentDepartment of Biostatistics and Medical Informatics, Faculty of Medicine, Erzincan Binali Yıldırım University, 24000 Erzincan, Türkiye.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)